对抗SARS-CoV-2变种的索特罗维马布中和能力的比较:快速计算方法的开发

Dana Ashoor1, Maryam Marzouq1, M-Dahmani Fathallah1

  • 1Department of Life Sciences, Health Biotechnology Program - King Fahad Chair for Health Biotechnology, College of Graduate Studies, Arabian Gulf University, Manama, Bahrain.

概括

一种新的计算方法快速评估针对SARS-CoV-2变体的单克隆抗体疗效. 它发现对Omicron变种的结合性下降,突出了像G339H/D这样的突变,使免疫逃避成为可能.